224 related articles for article (PubMed ID: 10890918)
1. Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses.
Stevenson PG; Efstathiou S; Doherty PC; Lehner PJ
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8455-60. PubMed ID: 10890918
[TBL] [Abstract][Full Text] [Related]
2. Retrovirus-induced changes in major histocompatibility complex antigen expression influence susceptibility to lysis by cytotoxic T lymphocytes.
Flyer DC; Burakoff SJ; Faller DV
J Immunol; 1985 Oct; 135(4):2287-92. PubMed ID: 2411792
[TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi infection does not impair major histocompatibility complex class I presentation of antigen to cytotoxic T lymphocytes.
Buckner FS; Wipke BT; Van Voorhis WC
Eur J Immunol; 1997 Oct; 27(10):2541-8. PubMed ID: 9368608
[TBL] [Abstract][Full Text] [Related]
4. Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells.
Hengel H; Esslinger C; Pool J; Goulmy E; Koszinowski UH
J Gen Virol; 1995 Dec; 76 ( Pt 12)():2987-97. PubMed ID: 8847504
[TBL] [Abstract][Full Text] [Related]
5. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
[TBL] [Abstract][Full Text] [Related]
6. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
Zügel U; Schoel B; Kaufmann SH
J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
[TBL] [Abstract][Full Text] [Related]
7. Immune evasion by a novel family of viral PHD/LAP-finger proteins of gamma-2 herpesviruses and poxviruses.
Früh K; Bartee E; Gouveia K; Mansouri M
Virus Res; 2002 Sep; 88(1-2):55-69. PubMed ID: 12297327
[TBL] [Abstract][Full Text] [Related]
8. The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion.
Kavanagh DG; Gold MC; Wagner M; Koszinowski UH; Hill AB
J Exp Med; 2001 Oct; 194(7):967-78. PubMed ID: 11581318
[TBL] [Abstract][Full Text] [Related]
9. In vivo treatment with a MHC class I-restricted blocking peptide can prevent virus-induced autoimmune diabetes.
von Herrath MG; Coon B; Lewicki H; Mazarguil H; Gairin JE; Oldstone MB
J Immunol; 1998 Nov; 161(9):5087-96. PubMed ID: 9794447
[TBL] [Abstract][Full Text] [Related]
10. K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus.
Stevenson PG; May JS; Smith XG; Marques S; Adler H; Koszinowski UH; Simas JP; Efstathiou S
Nat Immunol; 2002 Aug; 3(8):733-40. PubMed ID: 12101398
[TBL] [Abstract][Full Text] [Related]
11. Lytic cycle T cell epitopes are expressed in two distinct phases during MHV-68 infection.
Liu L; Flaño E; Usherwood EJ; Surman S; Blackman MA; Woodland DL
J Immunol; 1999 Jul; 163(2):868-74. PubMed ID: 10395681
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
13. Human herpes simplex virus (HSV)-specific CD8+ CTL clones recognize HSV-2-infected fibroblasts after treatment with IFN-gamma or when virion host shutoff functions are disabled.
Tigges MA; Leng S; Johnson DC; Burke RL
J Immunol; 1996 May; 156(10):3901-10. PubMed ID: 8621929
[TBL] [Abstract][Full Text] [Related]
14. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
Lustgarten J; Waks T; Eshhar Z
Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
[TBL] [Abstract][Full Text] [Related]
15. Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.
Shirai M; Pendleton CD; Berzofsky JA
J Immunol; 1992 Mar; 148(6):1657-67. PubMed ID: 1371784
[TBL] [Abstract][Full Text] [Related]
16. Suppression of MHC class I antigens in oncogenic transformants: association with decreased recognition by cytotoxic T lymphocytes.
Seliger B; Harders C; Wollscheid U; Staege MS; Reske-Kunz AB; Huber C
Exp Hematol; 1996 Sep; 24(11):1275-9. PubMed ID: 8862437
[TBL] [Abstract][Full Text] [Related]
17. A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells.
Tibbetts SA; Suarez F; Steed AL; Simmons JA; Virgin HW
Virology; 2006 Sep; 353(1):210-9. PubMed ID: 16797052
[TBL] [Abstract][Full Text] [Related]
18. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
19. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
[TBL] [Abstract][Full Text] [Related]
20. Cytomegalovirus encodes a positive regulator of antigen presentation.
Holtappels R; Gillert-Marien D; Thomas D; Podlech J; Deegen P; Herter S; Oehrlein-Karpi SA; Strand D; Wagner M; Reddehase MJ
J Virol; 2006 Aug; 80(15):7613-24. PubMed ID: 16840340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
